EQL Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:EQL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Nov 24	SellSEK 1,658,277	FÅRö Capital Ab	Company	26,000	SEK 63.78
03 Oct 24	BuySEK 280,700	Martin Kristofferson	Individual	5,000	SEK 56.14
24 May 24	BuySEK 2,536,136	Axel Schorling	Individual	53,903	SEK 47.05
24 May 24	BuySEK 2,536,136	Axel Schorling	Individual	53,903	SEK 47.05
12 Dec 23	SellSEK 9,900,002	FÅRö Capital Ab	Company	300,000	SEK 33.00

Insider Buying: EQL insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 68.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30%	Cadila Pharmaceuticals Limited	8,718,500	SEK 605.1m	0%	no data
27.9%	FÅRö Capital Ab	8,101,348	SEK 562.2m	-0.32%	98.22%
4.33%	SEB Investment Management AB	1,258,398	SEK 87.3m	0%	0.01%
1.51%	Carnegie Fonder AB	440,251	SEK 30.6m	0%	0.04%
1.07%	Axel Schorling	311,016	SEK 21.6m	0%	no data
1.06%	Cliens Kapitalförvaltning AB	306,928	SEK 21.3m	0%	0.06%
0.88%	Alexander Brising	256,543	SEK 17.8m	0%	no data
0.86%	Schroder Investment Management Limited	250,000	SEK 17.3m	0%	no data
0.73%	Amundi Asset Management SAS	213,260	SEK 14.8m	-5.3%	no data
0.07%	Martin Kristofferson	20,200	SEK 1.4m	32.9%	no data
0.047%	Anna Jonsson	13,729	SEK 952.8k	0%	no data
0.034%	Anders Mansson	10,000	SEK 694.1k	0%	no data
0.034%	Per Svangren	10,000	SEK 694.1k	0%	no data
0.0086%	Linda Neckmar	2,500	SEK 173.5k	0%	no data